Can metabolomic profiling predict response to therapy?

Nat Rev Rheumatol. 2019 Mar;15(3):129-130. doi: 10.1038/s41584-018-0136-z.

Authors

Catherine M McGrath¹, Stephen P Young²

Affiliations

¹ Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
² Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. s.p.young@bham.ac.uk.

PMID: 30531855
DOI: 10.1038/s41584-018-0136-z

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Arthritis, Rheumatoid*
Humans
Metabolome*
Metabolomics
Methotrexate
Systems Biology

Substances

Antibodies, Monoclonal, Humanized
tocilizumab
Methotrexate

Grants and funding